DIRECTOR DEALINGS: Hikma Pharma CEO Excercises Options, Acquires Shares

Fri, 08th Nov 2013 15:20

LONDON (Alliance News) - Hikma Pharmaceutical PLC Friday said that Chief Executive Officer Said Darwazah exercised share options and acquired 79,800 shares at a price of 1,195 per share.

Darwazah holds a 5.62% stake in the company, with a total of more than 11.1 million shares.

Shares in the pharmaceutical company were trading 0.6% lower Friday afternoon, at 1,203.00 pence per share.

By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty

Related Shares

More News

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 10:15

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

25 Apr 2024 08:01

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...